BioCentury
ARTICLE | Company News

Third Wave, Mitsubishi Corp. deal

April 10, 2006 7:00 AM UTC

The companies formed a JV - Third Wave Japan - to develop and commercialize molecular diagnostics and pharmacogenetics products in Japan and the Asia-Pacific region. TWTI will have worldwide rights ou...